Improving communication and trust between cancer families and care teams
Communication breakdowns between patients, parents, doctors, nurses and other medical professionals could result in unnecessary stress and...
Dream Further Campaign hits $2 million for cancer survivorship research and care
When childhood cancer survivor Ted Sibley finished his cancer treatment as a teenager, he received a t-shirt that said, “Finish Line.” He was...
Does body composition impact the severity of chemo side-effects in children?
The research questions started to percolate for pediatric oncologist Aman Wadhwa, MD, MSPH, as he made his rounds of the pediatric oncology uni...
CCRF-funded researcher is outsmarting the defenses of AML cancer cells
Shannon Conneely, MD, a pediatric hematologist-oncologist at Texas Children’s Hospital and researcher at Baylor College of Medicine, envision...
Discovering the cell origin of Ewing sarcoma
For decades, the question of Ewing sarcoma’s genetic beginnings has stumped scientists, leaving potential therapeutic targets...
Exploring unconventional paths to new treatments for childhood rhabdoid tumors
Capucine Van Rechem was still a teenager when cancer stole away both her parents. First her mother died of breast cancer, and then her father p...
CCRF-funded researcher to open immunotherapy clinical trial for hepatoblastoma
O’Neill, a recipient of the Emerging Scientist Award from Children’s Cancer Research Fund (CCRF), is studying a new therapy to treat children...
8 new scientists will kickstart their projects thanks to CCRF
Many great ideas go unexplored in the childhood cancer world due to a lack of funding. Thanks to donors like you, eight new projects are...
Setting the Stage for First-Ever Targeted Treatment of an Extremely Rare Sarcoma
Dr. Okimoto studies a deadly subset of sarcoma, cancer that develops in the bone or tissue, called CIC-DUX4 sarcoma. He estimates only about...
Sneaking past medulloblastoma’s micro-defenses
CCRF Emerging Scientist Award winner Giedre Krenciute is developing a Trojan horse of sorts to sneak past medulloblastoma’s armed defenses...
CCRF-funded researcher uses microscopic protein pathways to beat graft-versus-host disease
Kids like Alex often need blood or marrow transplants (BMTs) as part of their treatment plans. Typically, these transplants use immune cells...
Researchers investigate existing drugs to treat AML more safely
The last time Children’s Cancer Research Fund donors heard about Ani Deshpande, Ph.D. assistant professor at Sanford Burnham Prebys Medical...
Crossing international borders in retinoblastoma research
For kids, rare means fewer doctors understand how to treat their disease, it’s difficult to find and develop better treatments, and hard to...
Minnesota couple’s $925,000 gift funds leading edge cancer technology at the University of Minnesota
Above: Fritz and Glenda Corrigan, pictured with their children and grandchildren. In April 2021, staff at the University of Minnesota finished ...
Designing better weapons against cancer cells
Jae-Woong Chang, PhD, initially had his eye on medical school. But then his high school teacher pointed out: “Doctors can cure about only...
Engineering better treatments for AML
“This is a very innovative approach. Using precise gene editing, we hypothesize that we can change one protein in healthy hematopoietic stem...
CCRF uses impact investments to accelerate new treatments
For researchers, it’s known as “the valley of death.” It’s the often-unfunded middle territory between the early part of research, when new...
Tackling toxic elements to target terrible diseases
Tiny scraps of paper from newborn screening tests, each with a dried blood spot smaller than a dime, could unlock insights into how to...